HK Stock MarketDetailed Quotes

HUISHENG INTL (01340)

Watchlist
  • 0.056
  • +0.001+1.82%
Market Closed May 15 15:59 CST
51.68MMarket Cap-2.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HUISHENG INTL (01340) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
373.30%209.57M
-76.79%7.39M
-35.17%44.28M
-25.77%31.82M
-6.37%68.3M
130.85%42.86M
-10.26%72.95M
-63.86%18.57M
174.05%81.29M
2,665.34%51.38M
Operating income
373.30%209.57M
-76.79%7.39M
-35.17%44.28M
-25.77%31.82M
-6.37%68.3M
130.85%42.86M
-10.26%72.95M
-63.86%18.57M
174.05%81.29M
2,665.34%51.38M
Cost of sales
-373.29%-207M
79.08%-7.04M
35.83%-43.74M
18.21%-33.65M
4.14%-68.16M
-106.83%-41.14M
9.64%-71.11M
59.49%-19.89M
-147.87%-78.69M
-2,865.16%-49.1M
Operating expenses
-373.29%-207M
79.08%-7.04M
35.83%-43.74M
18.21%-33.65M
4.14%-68.16M
-106.83%-41.14M
9.64%-71.11M
59.49%-19.89M
-147.87%-78.69M
-2,865.16%-49.1M
Gross profit
374.17%2.57M
118.88%346K
292.75%542K
-206.69%-1.83M
-92.50%138K
229.56%1.72M
-29.25%1.84M
-158.23%-1.33M
224.92%2.6M
1,027.23%2.28M
Selling expenses
-421.74%-240K
0.00%-23K
13.21%-46K
23.33%-23K
34.57%-53K
16.67%-30K
6.90%-81K
29.41%-36K
-383.33%-87K
-292.31%-51K
Administrative expenses
38.44%-7.69M
34.82%-4.82M
14.91%-12.49M
10.47%-7.39M
24.19%-14.68M
12.64%-8.25M
-0.05%-19.36M
-24.78%-9.45M
-11.58%-19.35M
33.59%-7.57M
Profit from asset sales
----
----
----
----
----
----
----
94.17%-12K
----
---206K
Revaluation surplus
-213.08%-778K
-321.28%-624K
198.15%688K
347.37%282K
-340.07%-701K
-133.93%-114K
102.58%292K
-79.17%336K
10.10%-11.33M
--1.61M
-Changes in the fair value of financial assets
-213.08%-778K
-321.28%-624K
198.15%688K
347.37%282K
-340.07%-701K
-133.93%-114K
-62.37%292K
-90.42%336K
178.62%776K
--3.51M
-Changes in the fair value of other assets
----
----
----
----
----
----
----
----
-4.23%-12.1M
---1.89M
Impairment and provision
-3,075.06%-12.48M
-3.56%-3.25M
99.53%-393K
-1,013.37%-3.14M
-17,528.93%-84.36M
-93.09%344K
-89.60%484K
-26.55%4.98M
122.37%4.65M
--6.78M
-Impairment of property, machinery and equipment
----
----
----
----
---59.87M
----
----
----
16.95%-6.9M
----
-Other impairment is provision
-3,075.06%-12.48M
-3.56%-3.25M
98.40%-393K
-1,013.37%-3.14M
-5,159.30%-24.49M
-93.09%344K
-95.81%484K
-26.55%4.98M
192.48%11.55M
--6.78M
Special items of operating profit
125.74%3.22M
-48.57%1.8M
73.54%-12.51M
-25.39%3.51M
-700.98%-47.29M
3.53%4.7M
203.62%7.87M
281.63%4.54M
-138.09%-7.59M
-115.08%-2.5M
Operating profit
36.41%-15.39M
23.62%-6.57M
83.52%-24.21M
-425.61%-8.6M
-1,540.45%-146.94M
-69.01%-1.64M
71.20%-8.96M
-384.71%-968K
5.48%-31.1M
-93.66%340K
Financing cost
----
---5K
---5K
----
----
----
----
----
-11.93%-779K
-547.16%-1.14M
Earning before tax
36.43%-15.39M
23.56%-6.57M
83.52%-24.21M
-425.61%-8.6M
-1,540.45%-146.94M
-69.01%-1.64M
71.91%-8.96M
-21.15%-968K
5.12%-31.88M
-116.88%-799K
Tax
----
----
----
----
---3.35M
---3.35M
----
----
----
----
After-tax profit from continuing operations
36.43%-15.39M
23.56%-6.57M
83.89%-24.21M
-72.60%-8.6M
-1,577.82%-150.28M
-414.67%-4.98M
71.91%-8.96M
-21.15%-968K
13.19%-31.88M
-149.66%-799K
Earning after tax
36.43%-15.39M
23.56%-6.57M
83.89%-24.21M
-72.60%-8.6M
-1,577.82%-150.28M
-414.67%-4.98M
71.91%-8.96M
-21.15%-968K
13.19%-31.88M
-149.66%-799K
Minority profit
-47.06%162K
295.83%94K
105.18%306K
74.19%-48K
-78.44%-5.91M
66.37%-186K
-2,857.14%-3.31M
-237.22%-553K
-10.89%-112K
267.92%403K
Profit attributable to shareholders
36.56%-15.56M
22.03%-6.67M
83.02%-24.52M
-78.29%-8.55M
-2,457.52%-144.37M
-1,055.66%-4.8M
82.23%-5.65M
65.47%-415K
13.25%-31.77M
-165.01%-1.2M
Basic earnings per share
37.64%-0.0169
25.77%-0.0072
83.47%-0.0271
-79.63%-0.0097
-2,460.94%-0.1639
-980.00%-0.0054
82.27%-0.0064
64.29%-0.0005
13.22%-0.0361
33.33%-0.0014
Diluted earnings per share
37.64%-0.0169
25.77%-0.0072
83.47%-0.0271
-79.63%-0.0097
-2,460.94%-0.1639
-980.00%-0.0054
82.27%-0.0064
64.29%-0.0005
13.22%-0.0361
33.33%-0.0014
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 373.30%209.57M-76.79%7.39M-35.17%44.28M-25.77%31.82M-6.37%68.3M130.85%42.86M-10.26%72.95M-63.86%18.57M174.05%81.29M2,665.34%51.38M
Operating income 373.30%209.57M-76.79%7.39M-35.17%44.28M-25.77%31.82M-6.37%68.3M130.85%42.86M-10.26%72.95M-63.86%18.57M174.05%81.29M2,665.34%51.38M
Cost of sales -373.29%-207M79.08%-7.04M35.83%-43.74M18.21%-33.65M4.14%-68.16M-106.83%-41.14M9.64%-71.11M59.49%-19.89M-147.87%-78.69M-2,865.16%-49.1M
Operating expenses -373.29%-207M79.08%-7.04M35.83%-43.74M18.21%-33.65M4.14%-68.16M-106.83%-41.14M9.64%-71.11M59.49%-19.89M-147.87%-78.69M-2,865.16%-49.1M
Gross profit 374.17%2.57M118.88%346K292.75%542K-206.69%-1.83M-92.50%138K229.56%1.72M-29.25%1.84M-158.23%-1.33M224.92%2.6M1,027.23%2.28M
Selling expenses -421.74%-240K0.00%-23K13.21%-46K23.33%-23K34.57%-53K16.67%-30K6.90%-81K29.41%-36K-383.33%-87K-292.31%-51K
Administrative expenses 38.44%-7.69M34.82%-4.82M14.91%-12.49M10.47%-7.39M24.19%-14.68M12.64%-8.25M-0.05%-19.36M-24.78%-9.45M-11.58%-19.35M33.59%-7.57M
Profit from asset sales ----------------------------94.17%-12K-------206K
Revaluation surplus -213.08%-778K-321.28%-624K198.15%688K347.37%282K-340.07%-701K-133.93%-114K102.58%292K-79.17%336K10.10%-11.33M--1.61M
-Changes in the fair value of financial assets -213.08%-778K-321.28%-624K198.15%688K347.37%282K-340.07%-701K-133.93%-114K-62.37%292K-90.42%336K178.62%776K--3.51M
-Changes in the fair value of other assets ---------------------------------4.23%-12.1M---1.89M
Impairment and provision -3,075.06%-12.48M-3.56%-3.25M99.53%-393K-1,013.37%-3.14M-17,528.93%-84.36M-93.09%344K-89.60%484K-26.55%4.98M122.37%4.65M--6.78M
-Impairment of property, machinery and equipment -------------------59.87M------------16.95%-6.9M----
-Other impairment is provision -3,075.06%-12.48M-3.56%-3.25M98.40%-393K-1,013.37%-3.14M-5,159.30%-24.49M-93.09%344K-95.81%484K-26.55%4.98M192.48%11.55M--6.78M
Special items of operating profit 125.74%3.22M-48.57%1.8M73.54%-12.51M-25.39%3.51M-700.98%-47.29M3.53%4.7M203.62%7.87M281.63%4.54M-138.09%-7.59M-115.08%-2.5M
Operating profit 36.41%-15.39M23.62%-6.57M83.52%-24.21M-425.61%-8.6M-1,540.45%-146.94M-69.01%-1.64M71.20%-8.96M-384.71%-968K5.48%-31.1M-93.66%340K
Financing cost -------5K---5K---------------------11.93%-779K-547.16%-1.14M
Earning before tax 36.43%-15.39M23.56%-6.57M83.52%-24.21M-425.61%-8.6M-1,540.45%-146.94M-69.01%-1.64M71.91%-8.96M-21.15%-968K5.12%-31.88M-116.88%-799K
Tax -------------------3.35M---3.35M----------------
After-tax profit from continuing operations 36.43%-15.39M23.56%-6.57M83.89%-24.21M-72.60%-8.6M-1,577.82%-150.28M-414.67%-4.98M71.91%-8.96M-21.15%-968K13.19%-31.88M-149.66%-799K
Earning after tax 36.43%-15.39M23.56%-6.57M83.89%-24.21M-72.60%-8.6M-1,577.82%-150.28M-414.67%-4.98M71.91%-8.96M-21.15%-968K13.19%-31.88M-149.66%-799K
Minority profit -47.06%162K295.83%94K105.18%306K74.19%-48K-78.44%-5.91M66.37%-186K-2,857.14%-3.31M-237.22%-553K-10.89%-112K267.92%403K
Profit attributable to shareholders 36.56%-15.56M22.03%-6.67M83.02%-24.52M-78.29%-8.55M-2,457.52%-144.37M-1,055.66%-4.8M82.23%-5.65M65.47%-415K13.25%-31.77M-165.01%-1.2M
Basic earnings per share 37.64%-0.016925.77%-0.007283.47%-0.0271-79.63%-0.0097-2,460.94%-0.1639-980.00%-0.005482.27%-0.006464.29%-0.000513.22%-0.036133.33%-0.0014
Diluted earnings per share 37.64%-0.016925.77%-0.007283.47%-0.0271-79.63%-0.0097-2,460.94%-0.1639-980.00%-0.005482.27%-0.006464.29%-0.000513.22%-0.036133.33%-0.0014
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -